» Articles » PMID: 30364475

Torsades De Pointes with Pseudo-T Wave Alternans During Rociletinib Therapy: A Novel Manifestation of a Rare Side Effect

Overview
Date 2018 Oct 27
PMID 30364475
Citations 1
Authors
Affiliations
Soon will be listed here.
Citing Articles

Management of COVID-19 in cancer patients receiving cardiotoxic anti-cancer therapy. Future recommendations for cardio-oncology.

Kobat H, Elkonaissi I, Dorak M, Nabhani-Gebara S Oncol Rev. 2021; 15(1):510.

PMID: 33747366 PMC: 7967496. DOI: 10.4081/oncol.2021.510.

References
1.
Sequist L, Soria J, Goldman J, Wakelee H, Gadgeel S, Varga A . Rociletinib in EGFR-mutated non-small-cell lung cancer. N Engl J Med. 2015; 372(18):1700-9. DOI: 10.1056/NEJMoa1413654. View

2.
Pickham D, Flowers E, Drew B . Hyperglycemia is associated with corrected QT prolongation and mortality in acutely ill patients. J Cardiovasc Nurs. 2013; 29(3):264-70. PMC: 4140190. DOI: 10.1097/JCN.0b013e31827f174c. View

3.
Gastaldelli A, Emdin M, Conforti F, Camastra S, Ferrannini E . Insulin prolongs the QTc interval in humans. Am J Physiol Regul Integr Comp Physiol. 2000; 279(6):R2022-5. DOI: 10.1152/ajpregu.2000.279.6.R2022. View

4.
Lenihan D, Kowey P . Overview and management of cardiac adverse events associated with tyrosine kinase inhibitors. Oncologist. 2013; 18(8):900-8. PMC: 3755926. DOI: 10.1634/theoncologist.2012-0466. View

5.
Narayan S . T-wave alternans and the susceptibility to ventricular arrhythmias. J Am Coll Cardiol. 2006; 47(2):269-81. DOI: 10.1016/j.jacc.2005.08.066. View